The Efficacy of Acute Electroconvulsive Therapy in Atypical Depression
J Clin Psychiatry 2008;69(3):406-411
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Objective: This study examined the characteristics and
outcomes of patients with major depressive disorder (MDD), with or without
atypical features, who were treated with acute bilateral electroconvulsive
Method: Analyses were conducted with 489 patients who met
DSM-IV criteria for MDD. Subjects were identified as typical or atypical on the
basis of the Structured Clinical Interview for DSM-IV obtained at baseline
prior to ECT. Depression symptom severity was measured by the 24-item Hamilton
Rating Scale for Depression (HAM-D24) and the 30-item Inventory of
Depressive Symptomatology-Self-Report (IDS-SR30). Remission was
defined as at least a 60% decrease from baseline in HAM-D24 score
and a total score of 10 or below on the last 2 consecutive HAM-D24
ratings. The randomized controlled trial was performed from 1997 to 2004.
Results: The typical (N = 453) and atypical (N = 36) groups
differed in several sociodemographic and clinical variables including gender (p
= .0071), age (p = .0005), treatment resistance (p = .0014), and age at first
illness onset (p < .0001) and onset of current episode (p = .0008). Following
an acute course of bilateral ECT, a considerable portion of both the typical
(67.1%) and the atypical (80.6%) groups reached remission. The atypical group
was 2.6 (95% CI = 1.1 to 6.2) times more likely to remit than the typical group
after adjustment for age, psychosis, gender, clinical site, and depression
severity based on the HAM-D24.
Conclusion: Acute ECT is an efficacious treatment for
depressed patients with typical or atypical symptom features.